Gunnveig Grødeland

Vaccine molecules targeting Xcr1 on cross‐presenting DCs induce protective CD8⁺ T‐cell responses against influenza virus

Even Fossum, Gunnveig Grødeland, Dorothea Terhorst‐Molawi et al. · European Journal of Immunology · 2014 · 103 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Immunogenicity and Safety of Standard and <scp>Third‐Dose SARS</scp>–<scp>CoV</scp>‐2 Vaccination in Patients Receiving Immunosuppressive Therapy

Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter et al. · Arthritis & Rheumatology · 2022 · 65 citations · Full text

Medicine, Immunology, Clinical Immunology +16

DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza

Gunnveig Grødeland, Siri Mjaaland, Kenneth H. Roux et al. · The Journal of Immunology · 2013 · 58 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

Dung Nguyen, Peter Simmonds, Maurice Steenhuis et al. · Eurosurveillance · 2021 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants

Trung Tran, Eline Benno Vaage, Adi Mehta et al. · npj Vaccines · 2022 · 44 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15